Leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4) is produced in a broad spectrum of mouse embryonic and adult tissues and its deficiency results in embryonal or perinatal lethality. The LGR4 function was mainly related to its potentiation of canonical Wnt signaling; however, several recent studies associate LGR4 with additional signaling pathways. To obtain a suitable tool for studying the signaling properties of Lgr4, we generated a tagged variant of the Lgr4 receptor using gene targeting in the mouse oocyte. The modified Lgr4 allele expresses the Lgr4 protein fused with a triple hemagglutinin (3HA) tag located at the extracellular part of the protein. The allele is fully functional, enabling tracking of Lgr4 expression in the mouse tissues. We also show that via surface labeling, the 3HA tag allows direct isolation and analysis of living Lgr4-positive cells obtained from the small intestinal crypts. Finally, the HA tag-specific antibody can be employed to characterize the biochemical features of Lgr4 and to identify possible biding partners of the protein in cells derived from various mouse tissues.
Leucine-rich repeat-containing G-protein-coupled receptor 4 and related LGR5 and LGR6 proteins represents the B subgroup of transmembrane proteins related to the G-protein-coupled receptors (GPCRs) of the hormone receptor class (Hsu et al. 1998, 2014; McDonald et al. 1998). All LGRs are characterized by a large N-terminal extracellular domain containing tandem arrays of leucine-rich repeat (LRR) units. In contrast to the members of the LGR A and C subgroups that bind hormones to activate heterotrimeric G proteins (e.g., the subgroups are represented by the luteinizing hormone receptor and relaxin hormone receptors, respectively), the LGR4/5/6 receptors interact with secreted Wnt pathway agonists R-spondins (RSPOs) (Carmon et al. 2011; de Lau et al. 2011; Glinka et al. 2011). Wnt signaling potentiation is independent of the G-protein activation or β-arrestin translocation (Carmon et al. 2011; de Lau et al. 2011; Ruffner et al. 2012). Instead, RSPO ligand binding to LGR4/5 leads to cell surface clearance of homologous transmembrane E3 ubiquitin ligases ring finger 43 (RNF43) and zinc and ring finger 3 (ZNRF3). The ligases antagonize both canonical and non-canonical Wnt signaling through ubiquitination and degradation of Wnt receptors (Hao et al. 2012). In the RSPO presence, a specific RSPO–LGR4/5–RNF43/ZNRF3 complex is formed and the RNF43/ZNRF3 activity is suppressed by the complex internalization.
LGR4/5/6 proteins are highly homologous (their sequence identity is more than 50%); nevertheless, their expression pattern and cellular function(s) appear to be only partially overlapping. LGR5 was identified as a gene upregulated by aberrant Wnt signaling in human colon cancer cells (van de Wetering et al. 2002). Subsequent lineage tracing studies performed in genetically modified mice revealed that Lgr5 is specifically produced in epithelial stem cells that are localized at the base of epithelial invaginations (so-called crypts) of the small intestine and colon (Barker et al. 2007). Crypt cells form U-shaped structures comprising several hundred cells. Next to stem cells, each crypt harbors rapidly dividing transit-amplifying cells (progenitors) localized above the stem cell compartment. Additionally, in the small intestine, stem cells are intermixed with the Paneth cells, terminally differentiated cells producing anti-bacterial peptides and enzymes [reviewed in Krausova and Korinek (2014)]. Further studies recognized Lgr5 as a marker of adult stem cells in the stomach, hair follicle, mammary gland, and many other mouse tissues (Barker et al. 2010, 2012; de Visser et al. 2012; Jaks et al. 2008; Plaks et al. 2013; Yee et al. 2013). The other subgroup member, Lgr6, is expressed in the earliest hair placode during mouse embryonic development and in the region interconnecting hair follicles with sebaceous glands in adulthood (Snippert et al. 2010).
In contrast, Lgr4 is broadly expressed in proliferative compartments of many embryonic and adult tissues including the gastrointestinal tract, skin, liver, kidney, pancreas, mammary gland, and bone. Owing to the pleiotropic expression, Lgr4 deficiency is embryonically (or peri/prenatally) lethal (Leighton et al. 2001; Mazerbourg et al. 2004). Besides ubiquitin E3 ligase internalization, there is yet another LGR-related mechanism potentiating Wnt signaling. Upon RSPO–LGR4 interaction, LGR4 binds to the IQ motif containing GTPase activating protein 1 (IQGAP1) and increases IQGAP1 affinity to the cytoplasmic mediator of Wnt signaling Dishevelled (DVL). Subsequent formation of a supramolecular complex involving RSPO–LGR4 and Wnt signalosome “boosts” the canonical Wnt signaling pathway (Carmon et al. 2014). Recently, Luo and colleagues reported that Lgr4 functions as an alternative receptor for RANKL [also known as tumor necrosis factor (TNF) superfamily member 11 (TNFSF11)] (Luo et al. 2016). In addition, bone morphogenetic protein 2 (BMP2) antagonist norrin was identified as a new ligand for LGR4. The effect of norrin-LRP4 coupling on Wnt pathway potentiation is similar as that of the RSPO–LGR4 interaction (Deng et al. 2013). In contrast, Planas-Paz and colleagues have documented that during liver growth and regeneration, RSPO1–Lgr4–Rnf43/Znrf3 signaling does not just augment the Wnt pathway output, but is essential for Wnt signaling (Planas-Paz et al. 2016). Very recently, Yan and co-workers discovered that during intestinal stem cell maintenance and expansion, the Wnt and RSPO ligands play distinct roles (Yan et al. 2017). All the results indicate multiple modes of Lgr4-mediated signaling; however, detailed molecular mechanisms of the signal relay remain to be determined.
In the present study we describe generation of a new mouse strain dedicated to study the Lgr4-dependent function(s). The Lgr4 locus was modified by homologous recombination in the zygote using the transcription activator-like effector nucleases (TALENs)-based technology and exogenous DNA template. The resulting allele produces the Lgr4 protein fused with a 3HA tag at its N-terminus. The allele is fully functional, enabling easy tracking of Lgr4 expression in adult mouse tissues. Furthermore, since the tag is expressed on the cell surface, it allows direct isolation (and analysis) of living Lgr4-positive cells obtained from the mouse organs. Finally, Lgr4 new biding partners or postranslational modification(s) can be identified by mass spectrometry (MS) analysis of immunoprecipitates obtained using an HA tag-specific antibody.
Materials and methods
Housing of mice and in vivo experiments were performed in compliance with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and national and institutional guidelines. Animal care and experimental procedures were approved by the Animal Care Committee of the Institute of Molecular Genetics (Ref. 63/2013). The genetically modified mice were generated by microinjection of TALEN mRNAs in C57BL/6 J mouse eggs together with the template DNA. The template composed of 738 bp left homology arm, 93 bp sequence encoding the 3HA tag and 691 bp right homology arm was obtained as synthetic DNA (Genescript). TALENs were devised to cleave in the first Lgr4 exon downstream sequence coding for the signal peptide. TALENs were designed using TAL Effector Nucleotide Targeter 2.0 (https://tale-nt.cac.cornell.edu/) (Cermak et al. 2011; Doyle et al. 2012), assembled using the Golden Gate Cloning system (Cermak et al. 2011), and cloned into the ELD–KKR plasmid as described previously (Flemr et al. 2013). The assembled TALEN constructs were sequenced and transcribed in vitro as described previously (Kasparek et al. 2014). Microinjected eggs were transferred into foster mothers. The presence of the modified Lgr4 allele was screened from tail biopsies of 3-week-old pups by left and right arm PCR; the PCR products were sequenced. Animals harboring the knock-in allele were crossed with C57BL/6 J wild-type (wt) mice to produce heterozygous and homozygous animals. Lgr5–EGFP–CreERT2 mice [B6.129P2-Lgr5tm1(cre/ERT2)Cle/J] were purchased from The Jackson Laboratory (Bar Harbor, Maine, USA) and genotyped as described in the genotyping protocols of the provider using tail biopsies. Primer sequences are given in “Supplementary Table 1”. The mouse strain carrying the modified Lgr4 allele will be available via The European Mutant Mouse Archive (EMMA) repository (https://www.infrafrontier.eu/resources-and-services/access-emma-mouse-resources/major-collections).
Cell transfection and immunocytochemical staining
The 3HA–LGR4–FLAG construct encoding human LGR4 including N-terminal insertion of the 3HA tag (downstream signaling peptide) and with the FLAG tag at its C-terminus was generated in the pK-myc backbone (Valenta et al. 2006) using human LGR4 cDNA (NM_018490; purchased from OriGene) and a site-directed mutagenesis kit (Stratagene). HeLa cells were seeded in 20% confluency on cover slips in a 24-well dish. The next day, the cells were transfected with the 3HA–LGR4–FLAG construct using Lipofectamine 2000 reagent (Thermo Fisher Scientific). The cells were stained 24 h after transfection. Fixed/permeabilized cell staining: cells were washed with phosphate-buffered saline (PBS), fixed and permeabilized with methanol [20 min, at room temperature (RT)]. Next, the cells were incubated with a mouse anti-FLAG monoclonal antibody (clone M2; Sigma-Aldrich) for 1 h, washed with PBS and incubated with a rabbit anti-HA tag monoclonal antibody (clone C29F4; Cell Signaling Technology) (1 h, RT), washed and incubated with secondary goat anti-mouse antibody (45 min, RT; Alexa Flour 488 dye conjugate; Thermo Fisher Scientific), washed with PBS and incubated with goat anti-rabbit antibody (45 min, RT; Alexa Flour 594 dye conjugate; Thermo Fisher Scientific). Cells were washed with PBS and mounted in mowiol (Sigma-Aldrich). Living cell staining: the primary antibody was added to the culture medium of transfected cells growing on coverslips and incubated for 1 h at 37 °C (5% CO2). The dish was washed with PBS and incubated with a rabbit anti-HA monoclonal antibody (1 h, 37 °C, 5% CO2), washed with PBS and treated with methanol (20 min, RT). After additional wash, the cells were incubated with the secondary antibodies (45 min, RT), washed in PBS and mounted. The staining was visualized with a Leica DM6000 fluorescent microscope.
Organs/embryos were fixed with 4% formaldehyde (Sigma-Aldrich) overnight, dehydrated, and embedded in paraffin. Immunostaining with a primary antibody was performed on 6-µm sections after heat-induced antigen retrieval (steam bath, 20 min, specimens were immersed in Tris-EDTA buffer, pH 9) and blocking endogenous peroxidases and unspecific immunoglobulins. The following primary antibodies were used: anti-HA (rabbit monoclonal, clone C29F4; Cell Signaling Technology), anti-PCNA (rabbit polyclonal; Abcam) anti-GFP (chicken polyclonal; Abcam). Subsequently, the sections were incubated with biotin-conjugated secondary antibodies (Life Technologies) and detected by a peroxidase-based Vectastain ABC kit (Vector) with 3,3′-diaminobenzidine (DAB) substrate (Sigma-Aldrich), counterstained with hematoxylin and mounted in acrylic resin (Sigma-Aldrich).
Flow cytometry and quantitative RT-PCR (qRT-PCR)
Isolation of the small intestinal and colonic crypts was based on the protocol published by Sato and Clevers (2013). Briefly, small intestine or colon was flashed with PBS and cut longitudinally. The intestinal villi (small intestine) were scratch off using a microscopy slide. The tissue was washed extensively using PBS and incubated with 5 mM EDTA (30 min, 4 °C) to release crypts from the underlying connective tissue. Released crypts were filtrated through a 70-µm strainer (Thermo Fisher Scientific) and spun down. The pellet was processed for immunoblotting/immunoprecipitation or immunostaining. The pellet was incubated in serum-free media with dispase (Corning; 18U, 800RPM, 37 °C, 2 × 10 min). Single-cell suspension was spun down and incubated with an anti-HA biotin-conjugated rabbit monoclonal antibody (biotinylated clone C29F4; 15 min, 4 °C). Subsequently, the antibody was washed with Dulbecco’s Modified Eagle Medium (DMEM; Thermo Fisher Scientific) supplemented with 3% fetal bovine serum (FBS; Sigma-Aldrich) and the cells were incubated (15 min, ice) with streptavidin-allophycocyanine (APC) secondary antibody (BD Biosciences). The antibody was washed and the cells were analyzed by flow cytometry using an Influx high-speed cell sorter (BD Biosciences) and sorted to RNA lysis buffer (Qiagen). Gated areas were evaluated by FlowJo software (Tree Star). RNA was isolated from the sorted cells using an RNAeasy Micro kit according to the manufacturer’s protocol including DNAse treatment (Qiagen) and reverse transcribed using MAXIMA reverse transcriptase (Thermo Fisher Scientific). The LightCycler 480 apparatus and SYBR Green I Master Mix (Roche Applied Science) were employed for qRT-PCR. Primers are listed in Supplementary Table 1.
Immunoblotting (IB) and immunoprecipitation (IP)
Isolated cryptic cells or entire stomach tissue were homogenized in lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% NP40) supplemented with protease inhibitor cocktail (Roche). Samples were spun down at 20,000×g (10 min, 4 °C). Supernatant was directly mixed with Laemmli sample buffer. For IP, the supernatant was incubated with prewashed anti-HA tag magnetic beads (clone 2-2.2.14; Thermo Fisher scientific) in a carousel (1 h, 4 °C). Subsequently, the magnetic beads were washed three times with complete lysis buffer and twice with lysis buffer without detergent. To avoid centrifugation during the washing steps, magnetic beads were separated by a magnet and gently re-suspended in new buffer by inverting the tube. After the last washing step, the magnetic beads were frozen as a pellet in −80 °C and used for MS analysis. Alternatively, the magnetic beads were re-suspended in 50 µl lysis buffer, mixed with Laemmli sample buffer and used as for IB. Samples were boiled for 10 min and separated by vertical electrophoresis in 10% denaturation acrylamide gel, semidry blotted and incubated with a rabbit anti-HA monoclonal antibody (clone C29F4; Cell Signaling) or rabbit anti-β-actin (whole rabbit serum; Sigma-Aldrich).
The samples were cleaved directly on beads with 1 µg of trypsin (Sigma-Aldrich) at 37 °C overnight (Masuda et al. 2008). Neutral lost scan mass spectrometry (NLS-MS) analysis was performed according to Hebert et al. (2014). All data were analyzed and quantified with MaxQuant software (version 184.108.40.206) (Cox et al. 2014). The false discovery rate (FDR) was set to 1% for both proteins and peptides, and we specified a minimum length of seven amino acids. The Andromeda search engine was used for the MS/MS spectra search against the Mus musculus database (downloaded from Uniprot in March 2015, containing 44,654 entries). Enzyme specificity was set as C-terminal to Arg and Lys, also allowing cleavage at proline bonds and a maximum of two missed cleavages. Dithiomethylation of cysteine was selected as fixed modification and N-terminal protein acetylation and methionine oxidation as variable modifications. The “match between runs” feature of MaxQuant was used to transfer identifications to other LC–MS/MS runs based on their masses and retention time (maximum deviation 0.7 min) and this was also used in quantification experiments. Quantifications were performed with the label-free algorithms. Data analysis was performed using Perseus 220.127.116.11 software (Tyanova et al. 2016).
Results and discussion
Generation of Lgr43HA/3HA mice
To introduce a single-copy construct into the Lgr4 locus, we generated a TALEN pair specific for the sequence in the first Lgr4 exon. Furthermore, we generated a construct containing the 3HA tag sequence flanked by left and right homology “arms” derived from the corresponding regions of the Lgr4 locus (Fig. 1a). The construct was co-injected with TALEN mRNAs into fertilized eggs. From 373 transferred zygotes, 25 pups were born; sequencing of DNA fragments generated by PCR using genomic DNA isolated from tail biopsies revealed that 11 founders carried the 3HA tag sequence correctly inserted into the targeted locus. The PCR reactions were performed with two primer pairs priming upstream and inside (primers P1 and P2) or inside and downstream (primers P3 and P4) in the genomic region used for the production of the targeting construct. The 3HA tag was placed immediately downstream of the Lgr4 sequence encoding the signal peptide of the protein (Fig. 1b). To eliminate the possibility of random integration of the construct into the genome, we crossed three mice (two females and one male) with wild-type (wt) C57BL/6 J mice for five generations. For routine PCR-based genotyping, additional primer pairs (P4 and P6) generating a shorter PCR product were utilized (Fig. 1c). In the offspring of all three founders, the 3HA–Lgr4 allele was inherited in a standard Mendelian ratio, implicating a single integration site of the construct. In parallel, we tested the membrane localization and accessibility of the 3HA tag in the context of 3HA–Lgr4 fusion protein. HeLa cells were transiently transfected on coverslips with a construct encoding human 3HA–LGR4 containing a FLAG tag at its C-terminus. To capture the extracellular portion of the receptor, transfected growing cells were briefly incubated with an anti-HA and anti-FLAG antibody. The cells were washed, fixed (and permeabilized), and retained anti-HA or anti-FLAG immunoglobulins were directly stained with differentially labeled secondary antibodies reacting with rabbit (for HA detection) or mouse (FLAG detection) immunoglobulins. In parallel, the transfected cells were first fixed/permeabilized (to make both ends of the protein accessible) and then incubated with the primary and secondary antibodies. The assay confirmed that in living cells, the 3HA epitope was localized extracellularly and the FLAG tag was inaccessible. In contrast, in cells permeabilized prior to staining, both tags were detected (Fig. 1d). The functionality of the 3HA–Lgr4 protein was further confirmed in vivo when heterozygous mice of each founder were intercrossed. Viable and fertile Lgr43HA/3HA homozygotes for all three original founders were obtained and, subsequently, corresponding homozygous strains were established.
Immunohistochemical detection of 3HA–Lgr4 in the gastrointestinal tract and skin
Our next goal was to test whether the 3HA tag might be visualized by immunohistochemistry. Lgr4 is broadly expressed in various organs including the kidney, stomach, intestine, bladder, heart, brain, bone, male reproductive tract, eye, and skin (Kato et al. 2007; Mazerbourg et al. 2004; Mendive et al. 2006; Mohri et al. 2008). Since the main interest of our laboratory is the digestive tract, we primarily focused on 3HA tag expression in the small intestine, colon, and stomach. In the small intestine, Lgr4 production was tracked by various methods including mRNA in situ hybridization (Mustata et al. 2011), immunohistochemistry (Yi et al. 2013), and by the β-galactosidase (LacZ) reporter expressed from the Lgr4 locus (de Lau et al. 2011; Mustata et al. 2011). In concordance with the data published previously, the 3HA antigen was detected in all anatomical parts of the small intestine (duodenum, jejunum, and ileum). As expected, the strongest signal was observed in the lower portions of the crypts and the signal intensity decreased along the crypt-villus axis (Fig. 2a; A, A′, B, B′). The expression pattern of 3HA–Lgr4 in the colon showed the opposite gradient, with the strongest signal in differentiated cells located at the apical parts of the crypts and on the colonic surface (Fig. 2a; C, C′, D, D′). The staining pattern was in stark contrast to previously published results based on the Lgr4–LacZ reporter activity (Liu et al. 2013) or mRNA detection (Mustata et al. 2011). Nevertheless, our results matched the staining pattern obtained using Lgr4-specific monoclonal antibodies (Yi et al. 2013). A possible explanation for the observed discrepancy between mRNA and protein levels may be involvement of a yet undescribed mechanism regulating Lgr4 protein stability in the colon. In the stomach, 3HA–Lgr4 was visualized in the isthmic area of the glandular part directly under the gastric pits (Fig. 2a; E, E′, F, F′). We did not note any staining in the non-keratinized stratified epithelium of the nonglandular stomach reported previously by Barker and colleagues (Barker et al. 2010) or Mazerbourg and co-workers (Mazerbourg et al. 2004). The staining was based on the LacZ-reporter or immunohistochemistry, respectively. Of note, in the Barker’s article, the expression pattern of Lgr4 in the stomach was mentioned in the text only without any accompanying images. Finally, outside of the gastrointestinal tract we performed 3HA detection in the skin of Lgr43HA/3HA and control Lgr4+/+ mice. In the skin, Lgr4 has been described as a marker of hair stem cell expressed in the external root sheath (Kinzel et al. 2014; Mohri et al. 2008). As shown in Fig. 2c; G, G′, H, H′, the staining pattern of the 3HA tag in the skin of newborn mice reproduced well the published data.
Due to the fact that that TALENs-mediated cutting of genomic DNA starts in the dividing morula rather in the zygote (Li et al. 2014), the founder mice were genetic mosaics, i.e., more than two different alleles were detected in one mouse. Subsequent sequencing disclosed that the first founder in fact harbored four different alleles: wt, 3HA-modified, and two alleles with deletion 118 (including the first methionine deletion) and 34 nucleotides in the Lgr4 genomic sequence adjacent to the site targeted by TALENs. Similarly, the second founder harbored four alleles: wt, 3HA-modifed, 117 bp (including the first methionine deletion) and 29 bp deletions. The third founder carried three alleles: wt, 3HA-modified, and 38 bp deletion generating a frame-shift mutation causing premature translation stop after codon 64. Since all three founders were crossed with wt mice next to Lgr43HA/3HA mice, Lgr4 null animals were generated. The Lgr4-deficient strains were named according to the size of the Lgr4 deletions as Lgr4∆38/∆38, Lgr4∆117/∆117, and Lgr4∆118/∆118 mice (Fig. 2b). In all three cases, the knockout allele was transmitted to the next generation, but mating of heterozygotes did not result in production of Lgr4−/− knockout mice. We screened 12 l (64 animals in total) by PCR genotyping (primers P5 and P6) and obtained 20 (31%) wt, 44 (69%) heterozygotes, but no Lgr4-deficient animal. It was noted previously that the phenotype of an Lgr4 null animal is pleiotropic, dependent on the genetic background (Mazerbourg et al. 2004; Mendive et al. 2006). In C57BL/6 J mice, the Lgr4 absence (we employed Lgr4∆38/∆38 and Lgr4∆118/∆118 mice for the analysis) was manifested by various defects starting from embryonic day 13.5 (E13.5). At E18.5, the abnormalities included disturbed gut tissue, smaller bones with no evidence of mineralization, and the lungs were poorly developed with no signs of air sacs (not shown). Figure 2c shows typical pathological changes observed in the skin manifested by thin epidermis, substantially reduced number of hair follicles and lower number of proliferating cell nuclear antigen (PCNA)-positive cells.
Cell biology and biochemical assays using Lgr43HA/3HA mice
Our intention was to employ the tagged Lgr4 variant in various cell biology and biochemical assays. In this part we will provide several examples of such experiments. Isolated epithelial cells from the stomach, small intestine, and colon of wt and Lgr43HA/3HA mice were used to prepare total cell lysates (TCL) and perform IB and IP using an anti-HA tag-specific antibody. As shown in Fig. 3a, the procedures revealed a broad band corresponding to a protein of a putative size between 100 and 130 kDa in TCLs derived from the small intestine and colon of Lgr43HA/3HA but not wt mice. The size of the specific signal in TCL from the stomach was somewhat broader and smaller, probably due to partial degradation of the sample. A (relatively) weaker and sharp band matching the size of the protein present in TCLs from the small intestine and colon was obtained upon IP from the stomach sample, indicating N-terminal degradation of 3HA–Lgr4 in the lysate. A portion of the material retained on the anti-HA antibody-conjugated beads was also digested by trypsin and subjected to MS. In this pilot assay we used a limited amount of the material, and thus the only polypeptide detected (specifically) in the sample from Lgr43HA/3HA small intestine was Lgr4. Nevertheless, the assay confirmed the feasibility of the technique for future large-scale experiments (Fig. 3a).
Since the 3HA tag is expressed on the cell surface, we crossed Lgr43HA/3HA mice with Lgr5–EGFP–IRES–CreERT2 animals containing the EGFP–IRES–CreERT2 expression cassette inserted into the Lgr5 locus (the strain is designated as Lgr5–EGFP). Consequently, EGFP production can be used as a surrogate stem cell marker (Barker et al. 2007). Cells isolated from the small intestinal crypts were labeled with an anti-3HA tag-specific antibody and visualized by red fluorescent dye APC-conjugated secondary antibodies, and subjected to cell sorting according to red (APC) and green (GFP) fluorescent signal intensity. The sorted cells were divided into five “gates” and collected. While 3HA–Lgr4 single-positive cells (population S1) constituted 37% of all sorted cells in Lgr43HA/3HA/Lgr5–EGFP mice, the corresponding population in Lgr4+/+/Lgr5–EGFP constituted a negligible number (1.5%) of cells. Similarly, the double-positive cell Lgr4+/Lgr5+ population (S2 gate) constituted 5.7% cells in Lgr43HA/3HA/Lgr5–EGFP crypts, but only 0.53% cells in Lgr4+/+/Lgr5–EGFP samples, indicating the specificity of the 3HA tag-specific surface labeling. In contrast, Lgr5+ single-positive cells (S3) representing 6.7% in Lgr4+/+/Lgr5–EGFP constituted a minor fraction (1.8%) in Lgr43HA/3HA/Lgr5–EGFP. This shows that Lgr5 single-positive cells are rare and in most cases, Lgr5+ cells co-express Lgr4. Finally, two gated populations designated S4 and S5 represented Lgr4/5 double-negative cells of bigger or smaller size, respectively. The broader expression pattern of Lgr4 in the crypt bottom, in comparison, was also confirmed by immunohistochemical detection (Fig. 3b). Next, we isolated total RNA from the S1–S5 sorted cell populations obtained from Lgr43HA/3HA/Lgr5–EGFP crypt and performed qRT-PCR analysis using several epithelial cell lineage-specific markers (Fig. 3c). Since S5 cells express neither of the markers, we concluded that they represent (differentiated) enterocytes. As expected, single-positive Lgr4+ cells (S1 population), next to high levels of Lgr4 mRNA, also produced Paneth cell markers such as matrix metallopeptidase 7 (Mmp7) and alpha-defensin 5 (Def5) and multiple-alpha defensins detected by a common primer pair (designated as Crypt) (VanDussen and Samuelson 2010). Moreover, mucin 2 (Muc2) was also enriched in the S1 population, indicating that it also contains goblet cell precursors (VanDussen and Samuelson 2010). The S2 Lgr4/5+ cells possibly include genuine intestinal stem cells (co)expressing (next to Lgr4/5) the Wnt target gene Axin2. The S3 population displayed low Lgr4 expression and somewhat reduced levels of Lgr5 and Axin2. Since these cells produced Crypt, they might represent the secretory precursors localized above the stem cell zone (Buczacki et al. 2013). Finally, the Muc2-positive goblet cells might be included in the S4 Lgr4/5 double-negative cell population. The population also contains cells positive for Mmp7 and Crypt. However, the identity of the cells in unclear. We anticipate that the crypt cell lineage sorting will need (besides Lgr4 and Lgr5) more lineage-specific markers; nevertheless, surface Lgr4-specific labeling represents a good tool in this type of studies.
In summary, we generated a functional epitope-tagged Lgr4 allele that can be used to identify Lgr4 interacting partners and/or visualize Lgr4-positive cells in various mouse organs and tissues.
Bone morphogenic protein
Multiple alpha defensins
Leucine-rich repeat-containing G-protein-coupled receptor
Matrix metallopeptidase 7
Proliferating cell nuclear antigen
Transcription activator-like effector nuclease
Total cell lysates
Barker N et al (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449:1003–1007. doi:10.1038/nature06196
Barker N et al (2010) Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6:25–36. doi:10.1016/j.stem.2009.11.013
Barker N et al (2012) Lgr5(+ve) stem/progenitor cells contribute to nephron formation during kidney development. Cell Rep 2:540–552. doi:10.1016/j.celrep.2012.08.018
Buczacki SJ, Zecchini HI, Nicholson AM, Russell R, Vermeulen L, Kemp R, Winton DJ (2013) Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature 495:65–69. doi:10.1038/nature11965
Carmon KS, Gong X, Lin Q, Thomas A, Liu Q (2011) R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A 108:11452–11457. doi:10.1073/pnas.1106083108
Carmon KS, Gong X, Yi J, Thomas A, Liu Q (2014) RSPO–LGR4 functions via IQGAP1 to potentiate Wnt signaling. Proc Natl Acad Sci U S A 111:E1221–E1229. doi:10.1073/pnas.1323106111
Cermak T et al (2011) Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39:e82. doi:10.1093/nar/gkr218
Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M (2014) Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics MCP 13:2513–2526. doi:10.1074/mcp.M113.031591
de Lau W et al (2011) Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476:293–297. doi:10.1038/nature10337
de Visser KE et al (2012) Developmental stage-specific contribution of LGR5(+) cells to basal and luminal epithelial lineages in the postnatal mammary gland. J Pathol 228:300–309. doi:10.1002/path.4096
Deng C, Reddy P, Cheng Y, Luo CW, Hsiao CL, Hsueh AJ (2013) Multi-functional norrin is a ligand for the LGR4 receptor. J Cell Sci 126:2060–2068. doi:10.1242/jcs.123471
Doyle EL, Booher NJ, Standage DS, Voytas DF, Brendel VP, Vandyk JK, Bogdanove AJ (2012) TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction. Nucleic Acids Res 40:W117–W122. doi:10.1093/nar/gks608
Flemr M, Malik R, Franke V, Nejepinska J, Sedlacek R, Vlahovicek K, Svoboda P (2013) A retrotransposon-driven dicer isoform directs endogenous small interfering RNA production in mouse oocytes. Cell 155:807–816. doi:10.1016/j.cell.2013.10.001
Glinka A et al (2011) LGR4 and LGR5 are R-spondin receptors mediating Wnt/beta-catenin and Wnt/PCP signalling. EMBO Rep 12:1055–1061. doi:10.1038/embor.2011.175
Hao HX et al (2012) ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485:195–200. doi:10.1038/nature11019
Hebert AS, Richards AL, Bailey DJ, Ulbrich A, Coughlin EE, Westphall MS, Coon JJ (2014) The one hour yeast proteome. Mol Cell Proteomics MCP 13:339–347. doi:10.1074/mcp.M113.034769
Hsu SY, Liang SG, Hsueh AJ (1998) Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region. Mol Endocrinol 12:1830–1845. doi:10.1210/mend.12.12.0211
Hsu PJ, Wu FJ, Kudo M, Hsiao CL, Hsueh AJ, Luo CW (2014) A naturally occurring Lgr4 splice variant encodes a soluble antagonist useful for demonstrating the gonadal roles of Lgr4 in mammals. PLoS ONE 9:e106804. doi:10.1371/journal.pone.0106804
Jaks V, Barker N, Kasper M, van Es JH, Snippert HJ, Clevers H, Toftgard R (2008) Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat Genet 40:1291–1299. doi:10.1038/ng.239
Kasparek P, Krausova M, Haneckova R, Kriz V, Zbodakova O, Korinek V, Sedlacek R (2014) Efficient gene targeting of the Rosa26 locus in mouse zygotes using TALE nucleases. FEBS Lett 588:3982–3988. doi:10.1016/j.febslet.2014.09.014
Kato S, Mohri Y, Matsuo T, Ogawa E, Umezawa A, Okuyama R, Nishimori K (2007) Eye-open at birth phenotype with reduced keratinocyte motility in LGR4 null mice. FEBS Lett 581:4685–4690. doi:10.1016/j.febslet.2007.08.064
Kinzel B et al (2014) Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice. Dev Biol 390:181–190. doi:10.1016/j.ydbio.2014.03.009
Krausova M, Korinek V (2014) Wnt signaling in adult intestinal stem cells and cancer. Cell Signal 26:570–579. doi:10.1016/j.cellsig.2013.11.032
Leighton PA et al (2001) Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature 410:174–179. doi:10.1038/35065539
Li C et al (2014) Simultaneous gene editing by injection of mRNAs encoding transcription activator-like effector nucleases into mouse zygotes. Mol Cell Biol 34:1649–1658. doi:10.1128/MCB.00023-14
Liu S et al. (2013) Lgr4 gene deficiency increases susceptibility and severity of dextran sodium sulfate-induced inflammatory bowel disease in mice. J Biol Chem 288:8794–8803; discussion 8804. doi:10.1074/jbc.M112.436204
Luo J et al (2016) LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption. Nat Med 22:539–546. doi:10.1038/nm.4076
Masuda T, Tomita M, Ishihama Y (2008) Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis. J Proteome Res 7:731–740. doi:10.1021/pr700658q
Mazerbourg S et al (2004) Leucine-rich repeat-containing, G protein-coupled receptor 4 null mice exhibit intrauterine growth retardation associated with embryonic and perinatal lethality. Mol Endocrinol 18:2241–2254. doi:10.1210/me.2004-0133
McDonald T, Wang R, Bailey W, Xie G, Chen F, Caskey CT, Liu Q (1998) Identification and cloning of an orphan G protein-coupled receptor of the glycoprotein hormone receptor subfamily. Biochem Biophys Res Commun 247:266–270. doi:10.1006/bbrc.1998.8774
Mendive F, Laurent P, Van Schoore G, Skarnes W, Pochet R, Vassart G (2006) Defective postnatal development of the male reproductive tract in LGR4 knockout mice. Dev Biol 290:421–434. doi:10.1016/j.ydbio.2005.11.043
Mohri Y, Kato S, Umezawa A, Okuyama R, Nishimori K (2008) Impaired hair placode formation with reduced expression of hair follicle-related genes in mice lacking Lgr4. Dev Dyn 237:2235–2242. doi:10.1002/dvdy.21639
Mustata RC, Van Loy T, Lefort A, Libert F, Strollo S, Vassart G, Garcia MI (2011) Lgr4 is required for Paneth cell differentiation and maintenance of intestinal stem cells ex vivo. EMBO Rep 12:558–564. doi:10.1038/embor.2011.52
Plaks V et al (2013) Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis. Cell Rep 3:70–78. doi:10.1016/j.celrep.2012.12.017
Planas-Paz L et al (2016) The RSPO–LGR4/5–ZNRF3/RNF43 module controls liver zonation and size. Nat Cell Biol 18:467–479. doi:10.1038/ncb3337
Ruffner H et al (2012) R-spondin potentiates Wnt/beta-catenin signaling through orphan receptors LGR4 and LGR5. PLoS ONE 7:e40976. doi:10.1371/journal.pone.0040976
Sato T, Clevers H (2013) Primary mouse small intestinal epithelial cell cultures. Methods Mol Biol 945:319–328. doi:10.1007/978-1-62703-125-7_19
Snippert HJ et al (2010) Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 327:1385–1389. doi:10.1126/science.1184733
Tyanova S et al (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13:731–740. doi:10.1038/nmeth.3901
Valenta T, Lukas J, Doubravska L, Fafilek B, Korinek V (2006) HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies. EMBO J 25:2326–2337. doi:10.1038/sj.emboj.7601147
van de Wetering M et al (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241–250
VanDussen KL, Samuelson LC (2010) Mouse atonal homolog 1 directs intestinal progenitors to secretory cell rather than absorptive cell fate. Dev Biol 346:215–223. doi:10.1016/j.ydbio.2010.07.026
Yan KS et al (2017) Non-equivalence of Wnt and R-spondin ligands during Lgr5 + intestinal stem-cell self-renewal. Nature 545:238–242. doi:10.1038/nature22313
Yee KK, Li Y, Redding KM, Iwatsuki K, Margolskee RF, Jiang P (2013) Lgr5–EGFP marks taste bud stem/progenitor cells in posterior tongue. Stem Cells 31:992–1000. doi:10.1002/stem.1338
Yi J, Xiong W, Gong X, Bellister S, Ellis LM, Liu Q (2013) Analysis of LGR4 receptor distribution in human and mouse tissues. PLoS ONE 8:e78144. doi:10.1371/journal.pone.0078144
We thank S. Takacova for critically reading the manuscript. We also thank P. Talacko and K. Harant for mass spectrometry analysis. We express our special thanks to R. Sedlacek, P. Kasparek, and the members of the Transgenic and Archiving Module, the Czech Centre for Phenogenomics (CCP), for generation of transgenic mice. This work was supported by the Grant Agency of the Czech Republic Grant No. 14-33952S, by the Ministry of Education, Youth and Sports (project LO1419), and by the Academy of Sciences of the Czech Republic (RVO 68378050). Animal work was supported by CCP (project no. LM2015040) and OP RDI CZ.1.05/2.1.00/19.0395 (project: Higher quality and capacity for transgenic models).
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Kriz, V., Krausova, M., Buresova, P. et al. Establishment of a tagged variant of Lgr4 receptor suitable for functional and expression studies in the mouse. Transgenic Res 26, 689–701 (2017). https://doi.org/10.1007/s11248-017-0027-0
- Genome editing
- Hemagglutinin tag
- Wnt signaling